{
  "npi": "1568667996",
  "enumeration_type": "NPI-2",
  "basic": {
    "authorized_official_credential": "M.D.",
    "authorized_official_first_name": "ABBAS",
    "authorized_official_last_name": "MOTAZEDI",
    "authorized_official_name_prefix": "--",
    "authorized_official_name_suffix": "--",
    "authorized_official_telephone_number": "2022690381",
    "authorized_official_title_or_position": "CEO",
    "enumeration_date": "2007-06-16",
    "last_updated": "2007-07-10",
    "organization_name": "ABBAS MOTAZEDI, MD",
    "organizational_subpart": "NO",
    "status": "A"
  },
  "taxonomies": [
    {
      "code": "207RE0101X",
      "desc": "Internal Medicine, Endocrinology, Diabetes & Metabolism",
      "license": "MD11580",
      "primary": true,
      "state": "DC",
      "taxonomy_group": "193400000X - Single Specialty Group"
    }
  ],
  "enrichment": {
    "plain_english_specialty": "Board-Certified Endocrinologist (Diabetes, Thyroid & Hormone Specialist)",
    "certifying_board": "American Board of Internal Medicine — Endocrinology, Diabetes & Metabolism",
    "common_medicare_procedures": [
      "Continuous Glucose Monitoring (CGM) & Insulin Pump Titration (CPT 95251)",
      "Thyroid Ultrasound & Fine-Needle Aspiration (FNA) Biopsy of Thyroid Nodules",
      "DEXA Bone Mineral Density Interpretation for Osteoporosis",
      "Comprehensive Pituitary, Adrenal & Reproductive Hormone Panels"
    ],
    "common_part_d_therapeutic_classes": [
      "GLP-1 / GIP Receptor Agonists (Semaglutide, Tirzepatide) & Insulins",
      "Levothyroxine (Hypothyroidism) & Methimazole / Carbimazole (Hyperthyroidism)",
      "Metformin, Empagliflozin & Dapagliflozin",
      "Bisphosphonates (Alendronate, Zoledronic Acid) & Denosumab"
    ]
  }
}